Postoperative Prognosis Prediction of Pancreatic Cancer With Seven MicroRNAs

Pancreas

Volumn 44, Issue 5, 2015, Pages 764-768

  Lee, Kwang Hyuck ^a   Lee, Jong Kyun ^a   Choi, Dong Wook ^a   Do, In Gu ^a   Sohn, Insuk ^a   Jang, Kee Taek ^a   Jung, Sin Ho ^a,b   Heo, Jin Seok ^a   Choi, Seong Ho ^a   Lee, Kyu Taek ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

formalin fixed paraffin embedded specimens; microarray; microRNA; pancreatic cancer; prognosis

Indexed keywords

CA 19-9 ANTIGEN; HSA MICRORNA 150; HSA MICRORNA 194; HSA MICRORNA 342 3P; HSA MICRORNA 487B; HSA MICRORNA 664; HSA MICRORNA 99A; MICRORNA; MICRORNA 375; PARAFFIN; UNCLASSIFIED DRUG; TUMOR MARKER;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GENE EXPRESSION; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; OVERALL SURVIVAL; PANCREAS CANCER; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; ADVERSE EFFECTS; AGED; DISEASE COURSE; DNA MICROARRAY; FROZEN SECTION; GENE EXPRESSION PROFILING; GENETICS; MIDDLE AGED; MORTALITY; PANCREAS RESECTION; PANCREATIC NEOPLASMS; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; TREATMENT OUTCOME; TUMOR RECURRENCE;

AGED; BIOMARKERS, TUMOR; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; FROZEN SECTIONS; GENE EXPRESSION PROFILING; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PANCREATECTOMY; PANCREATIC NEOPLASMS; PARAFFIN EMBEDDING; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84932600249     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0000000000000346     Document Type: Article

References (17)

1. Schultz NA, Andersen KK, Roslind A, et al. Prognostic MicroRNAs in cancer tissue from patients operated for pancreatic cancer-five MicroRNAs in a prognostic index. World J Surg. 2012;36:2699-2707.
2. Jamieson NB, Morran DC, Morton JP, et al. MicroRNA molecular profiles associated with diagnosis, clinicopathologic criteria, and overall survival in patients with resectable pancreatic ductal adenocarcinoma. Clin Cancer Res. 2012;18:534-545.
3. Kim C, Paik S. Gene-expression-based prognostic assays for breast cancer. Nat Rev Clin Oncol. 2010;7:340-347.
4. Geiss GK, Bumgarner RE, Birditt B, et al. Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat Biotechnol. 2008;26:317-325.
5. Wang W, Corrigan-Cummins M, Hudson J, et al. MicroRNA profiling of follicular lymphoma identifies microRNAs related to cell proliferation and tumor response. Haematologica. 2012;97:586-594.
6. Bock C, Kiskinis E, Verstappen G, et al. Reference Maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell. 2011;144:439-452.
7. Singh H, Figliola MJ, Dawson MJ, et al. Reprogramming CD19-specific T cells with IL-21 signaling can improve adoptive immunotherapy of B-lineage malignancies. Cancer Res. 2011;71:3516-3527.
8. Schwanhausser B, Busse D, Li N, et al. Global quantification of mammalian gene expression control. Nature. 2011;473:337-342.
9. Lebedeva S, Jens M, Theil K, et al. Transcriptome-wide analysis of regulatory interactions of the RNA-binding protein HuR. Mol Cell. 2011;43:340-352.
10. Ozsolak F, Milos PM. RNA sequencing: advances, challenges and opportunities. Nat Rev Genet. 2011;12:87-98.
11. Simon RM, Subramanian J, Li MC, et al. Using cross-validation to evaluate predictive accuracy of survival risk classifiers based on high-dimensional data. Brief Bioinform. 2011;12:203-214.
12. Missiaglia E, Williamson D, Chisholm J, et al. PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification. JClinOncol.2012;30:1670-1677.
13. Funel N, Giovannetti E, Pollina LE, et al. Critical role of laser microdissection for genetic, epigenetic and proteomic analyses in pancreatic cancer. Expert Rev Mol Diagn. 2011;11:695-701.
14. Jung DE, Wen J, Oh T, et al. Differentially expressed microRNAs in pancreatic cancer stem cells. Pancreas. 2011;40:1180-1187.
15. Srivastava SK, Bhardwaj A, Singh S, et al. MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells. Carcinogenesis. 2011;32:1832-1839.
16. Basu A, Alder H, Khiyami A, et al. MicroRNA-375 and MicroRNA-221: potential noncoding RNAs associated with antiproliferative activity of benzyl isothiocyanate in pancreatic cancer. Genes Cancer. 2011;2:108-119.
17. LaConti JJ, Shivapurkar N, Preet A, et al. Tissue and serum microRNAs in the Kras(G12D) transgenic animal model and in patients with pancreatic cancer. PLoS One. 2011;6:e20687.